Ethanolamine benzoate compounds
US5266591A · kind A · utility
11Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 20, 1992 |
| Grant date | Nov 30, 1993 |
| Priority date | — |
| Expiry date | Nov 20, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compounds are ethanolamine benzoate compounds useful for the treatment of syndrome X, and of hypertension in patients who are insulin resistant or have one or more metabolic anomalies. A compound disclosed is S-1-(m-trifluoromethylphenyl)-2-{.beta.-{4-[2-(N-(3,3-diphenylpropionyl)am ino)ethyl] benzoyloxy}ethylamino} propane.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.